MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3

Yu,Zhanjiang; Zhang,Wei; Deng,Fengchun

doi:10.3892/ol.2015.3390

MicroRNA-577 inhibits gastric cancer growth by targeting E2F transcription factor 3

Authors:
- Zhanjiang Yu
- Wei Zhang
- Fengchun Deng
View Affiliations

Affiliations: Department of General Surgery, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161006, P.R. China, Department of Endocrinology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang 161006, P.R. China, Department of Anatomy, Qiqihar Medical University, Qiqihar, Heilongjiang 161006, P.R. China
Published online on: June 17, 2015 https://doi.org/10.3892/ol.2015.3390
Pages: 1447-1452

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The incidence and mortality rates of gastric cancer are one of the highest of all types of cancers. Emerging evidence has demonstrated that altered expression of micro (mi)RNAs may be implicated in the tumorigenesis of numerous types of cancer. Therefore, miRNAs may have potential as important tools in cancer diagnostics and therapeutics. miRNAs regulate the expression of genes involved in mediating cell proliferation and developmental timing, among numerous other processes. Altered expression levels of miRNAs may result in the ability of cells to proliferate aberrantly and migrate. The present study used reverse transcription‑quantitative polymerase chain reaction assays to analyze miRNA‑577 expression in gastric cancer tissues and cell lines, MTT and cell cycle analysis to examine cell proliferation in vitro, and luciferase assays and western blot to investigate miRNA‑577's downstream targets. The results demonstrated that miRNA‑577 was significantly downregulated in gastric cancer patient samples and cell lines. In addition, miRNA‑577 affected an important regulator of E2F transcription factor 3 expression and that altered miRNA‑577 expression resulted in the aberrant proliferation of gastric cancer cells.

View Figures

View References

1	Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxMarch 31–2014
2	Fock KM: Review article: The epidemiology and prevention of gastric cancer. Aliment Pharmacol Ther. 40:250–260. 2014. View Article : Google Scholar : PubMed/NCBI
3	Ferlay J, Soerjomataram I, Ervik M, et al; International Agency for Research on Cancer. GLOBOCAN 2012 Cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.frNovember 20–2014
4	Howlader N, Noone AM, Krapcho M, et al; National Cancer Institute. SEER Cancer statistics review, 1975–2011. http://seer.cancer.gov/csr/1975_2011/June 21–2014
5	Makeyev EV and Maniatis T: Multilevel regulation of gene expression by microRNAs. Science. 319:1789–1790. 2008. View Article : Google Scholar : PubMed/NCBI
6	Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar : PubMed/NCBI
7	Alvarez-Garcia I and Miska EA: MicroRNA functions in animal development and human disease. Development. 132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
8	Leung AK and Sharp PA: MicroRNA functions in stress responses. Mol Cell. 40:205–215. 2010. View Article : Google Scholar : PubMed/NCBI
9	Yan B, Zhao LH, Guo JT and Zhao JL: miR-429 regulation of osmotic stress transcription factor 1 (OSTF1) in tilapia during osmotic stress. Biochem Biophys Res Commun. 426:294–298. 2012. View Article : Google Scholar : PubMed/NCBI
10	DeSano JT and Xu L: MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J. 11:682–692. 2009. View Article : Google Scholar : PubMed/NCBI
11	Esquela-Kerscher A and Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
12	Zhu W, He J, Chen D, et al: Expression of miR-29c, miR-93 and miR-429 as potential biomarkers for detection of early stage non-small lung cancer. PLoS One. 9:e877802014. View Article : Google Scholar : PubMed/NCBI
13	Schultz NA, Dehlendorff C, Jensen BV, et al: MicroRNA biomarkers in whole blood for detection of pancreatic cancer. JAMA. 311:392–404. 2014. View Article : Google Scholar : PubMed/NCBI
14	Ahmed FE, Ahmed NC, Vos PW, et al: Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle. Cancer Genomics Proteomics. 10:93–113. 2013.
15	Li J, Du L, Yang Y, et al: MiR-429 is an independent prognostic factor in colorectal cancer and exerts its anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90. 2013. View Article : Google Scholar : PubMed/NCBI
16	Wang Y, Li M, Zang W, et al: MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol (Dordr). 36:385–394. 2013. View Article : Google Scholar : PubMed/NCBI
17	Krützfeldt J, Rajewsky N, Braich R, et al: Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
18	Yuan X, He J, Sun F and Gu J: Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma. Int J Clin Exp Pathol. 6:2651–2667. 2013.PubMed/NCBI
19	Kim CH, Kim HK, Rettig RL, et al: miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics. 4:792011. View Article : Google Scholar : PubMed/NCBI
20	Wei Z, Jiang S, Zhang Y, et al: The effect of microRNAs in the regulation of human CYP3A4: A systematic study using a mathematical model. Sci Rep. 4:42832014. View Article : Google Scholar : PubMed/NCBI
21	Suzuki T, Yasui W, Yokozaki H, Naka K, Ishikawa T and Tahara E: Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer. 81:535–538. 1999. View Article : Google Scholar : PubMed/NCBI
22	Ciafre SA and Galardi S: microRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer. RNA biol. 10:935–942. 2013. View Article : Google Scholar : PubMed/NCBI
23	Lai JP, Chien JR, Moser DR, et al: hSulf1 Sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology. 126:231–248. 2004. View Article : Google Scholar : PubMed/NCBI
24	Nojima H: G1 and S-phase checkpoints, chromosome instability, and cancer. Methods Mol Biol. 280:3–49. 2004.PubMed/NCBI
25	Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S and Lees JA: E2f3 is critical for normal cellular proliferation. Genes Dev. 14:690–703. 2000. Bartek J and Lukas J: Mammalian G1- and S-phase checkpoints in response to DNA damage. Curr Opin Cell Biol. 13:738–747. 2001.PubMed/NCBI
26	Lee MY, Moreno CS and Saavedra HI: E2F activators signal and maintain centrosome amplification in breast cancer cells. Mol Cell Biol. 34:2581–2599. 2014. View Article : Google Scholar : PubMed/NCBI
27	Nevins JR: The Rb/E2F pathway and cancer. Hum Mol Genet. 10:699–703. 2001. View Article : Google Scholar : PubMed/NCBI
28	Xiao F, Zhang W, Chen L, et al: MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma. J Transl Med. 11:1952013. View Article : Google Scholar : PubMed/NCBI
29	Leone G, DeGregori J, Yan Z, et al: E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev. 12:2120–2130. 1998. View Article : Google Scholar : PubMed/NCBI
30	Olsson AY, Feber A, Edwards S, et al: Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 26:1028–1037. 2007. View Article : Google Scholar : PubMed/NCBI
31	Ren XS, Yin MH, Zhang X, et al: Tumor-suppressive microRNA-449a induces growth arrest and senescence by targeting E2F3 in human lung cancer cells. Cancer Lett. 344:195–203. 2014. View Article : Google Scholar : PubMed/NCBI
32	Hollern DP, Honeysett J, Cardiff RD and Andrechek ER: The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer. Mol Cell Biol. 34:3229–3243. 2014. View Article : Google Scholar : PubMed/NCBI